Despite emerging evidence linking early elevated HMGB1 levels with the risk of post-stroke cognitive dysfunction, most prior studies had small sample sizes and measured HMGB1 beyond the initial 24-hour period when neuroinflammatory processes rapidly escalated. The gene discussed is HMGB1; the disease is stroke disorder.